No photo of Liudmila V Danilova

View Scopus Profile

Liudmila V Danilova

Research Associate

20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Neoplasms Medicine & Life Sciences
Genome Medicine & Life Sciences
Genes Chemical Compounds
Atlases Medicine & Life Sciences
Tumors Chemical Compounds
Mutation Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
DNA Methylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x)

Smith, K., Llosa, N., Cottrell, T. R., Siegel, N., Fan, H., Suri, P., Chan, H. Y., Guo, H., Oke, T., Awan, A. H., Verde, F., Danilova, L. V., Anagnostou, V., Tam, A. J., Luber, B. S., Bartlett, B. R., Aulakh, L. K., Sidhom, J. W., Zhu, Q., Sears, C. L. & 21 othersCope, L., Sharfman, W., Thompson, E., Riemer, J., Marrone, K., Naidoo, J., Velculescu, V. E., Forde, P., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., Durham, J. N., Wang, H., Le, D., Justesen, S., Taube, J. M., Diaz, L. A., Brahmer, J., Pardoll, A. M., Anders, R. A. & Housseau, F., Mar 6 2019, In : Journal for immunotherapy of cancer. 7, 1, 7.

Research output: Contribution to journal › Comment/debate

Consultants
Oncogenes
T-Lymphocytes
Conflict of Interest
Organized Financing

Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer

Saleh, A. D., Cheng, H., Martin, S. E., Si, H., Ormanoglu, P., Carlson, S., Clavijo, P. E., Yang, X., Das, R., Cornelius, S., Couper, J., Chepeha, D., Danilova, L. V., Harris, T. M., Prystowsky, M. B., Childs, G. J., Smith, R. V., Gordon Robertson, A., Jones, S. J. M., Cherniack, A. D. & 6 othersKim, S. S., Rait, A., Pirollo, K. F., Chang, E. H., Chen, Z. & Van Waes, C., Jan 1 2019, In : Clinical Cancer Research. 25, 9, p. 2860-2873 14 p.

Research output: Contribution to journal › Article

Nanomedicine
Head and Neck Neoplasms
MicroRNAs
Atlases
Neoplasms

Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response

Stein, J. E., Soni, A., Danilova, L. V., Cottrell, T. R., Gajewski, T. F., Hodi, F. S., Bhatia, S., Urba, W. J., Sharfman, W., Wind-Rotolo, M., Edwards, R., Lipson, E. & Taube, J. M., Apr 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 589-596 8 p.

Research output: Contribution to journal › Article

Open Access
Secondary Prevention
Melanoma
Biomarkers
Biopsy
Therapeutics

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Smith, K., Llosa, N., Cottrell, T. R., Siegel, N., Fan, H., Suri, P., Chan, H. Y., Guo, H., Oke, T., Awan, A. H., Verde, F., Danilova, L. V., Anagnostou, V., Tam, A. J., Luber, B. S., Bartlett, B. R., Aulakh, L. K., Sidhom, J. W., Zhu, Q., Sears, C. L. & 21 othersCope, L., Sharfman, W., Thompson, E., Riemer, J., Marrone, K., Naidoo, J., Velculescu, V. E., Forde, P., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., Durham, J. N., Wang, H., Le, D., Justesen, S., Taube, J. M., Diaz, L. A., Brahmer, J., Pardoll, A. M., Anders, R. A. & Housseau, F., Feb 11 2019, In : Journal for immunotherapy of cancer. 7, 1, 40.

Research output: Contribution to journal › Article

Open Access
Oncogenes
T-Lymphocytes
Biomarkers
DNA Mismatch Repair
Neoplasms

Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival

Danilova, L. V., Ho, W. J., Zhu, Q., Vithayathil, T., De Jesus-Acosta, A., Azad, N., Laheru, D., Fertig, E., Anders, R. A., Jaffee, E. & Yarchoan, M., Jun 1 2019, In : Cancer Immunology Research. 7, 6, p. 886-895 10 p.

Research output: Contribution to journal › Article

Adenocarcinoma
Cell Death
Ligands
Survival
Biomarkers